Cargando…

Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor

Detalles Bibliográficos
Autores principales:	Goel, Arun Kumar, Singh, Dinesh
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930294/ https://www.ncbi.nlm.nih.gov/pubmed/20838543 http://dx.doi.org/10.4103/0971-5851.64252

Ejemplares similares

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization
por: Gee, Julia MW, et al.
Publicado: (2003)

A new analysis approach of epidermal growth factor receptor pathway activation patterns provides insights into cetuximab resistance mechanisms in head and neck cancer
por: von der Heyde, Silvia, et al.
Publicado: (2012)

Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
por: Singh, Tripti, et al.
Publicado: (2015)

Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
por: Koya, Daisuke
Publicado: (2015)

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications
por: Zimmermann, Michel, et al.
Publicado: (2006)

The in vitro radiosensitivity of human head and neck cancers.
por: BjÃ¶rk-Eriksson, T., et al.
Publicado: (1998)

Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?
por: Musgrove, Elizabeth A
Publicado: (2004)

Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors
por: Barnes, Precious, et al.
Publicado: (2020)

Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells
por: Yu, Tosol, et al.
Publicado: (2016)

Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation
por: Koch, Dominik Thomas, et al.
Publicado: (2017)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
por: Russell, Jeffery S., et al.
Publicado: (2012)

Selective Uptake and Imaging of Aptamer- and Antibody-Conjugated Hollow Nanospheres Targeted to Epidermal Growth Factor Receptors Overexpressed in Head and Neck Cancer
por: Melancon, Marites Pasuelo, et al.
Publicado: (2014)

Exons 19 and 21 of Epidermal Growth Factor Receptor Are Highly Conserved in Squamous Cell Cancer of the Head and Neck
por: Carlson, Matthew, et al.
Publicado: (2009)

Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells
por: Li, Ping, et al.
Publicado: (2013)

Silencing human epidermal growth factor receptor‐3 radiosensitizes human luminal A breast cancer cells
por: He, Guofeng, et al.
Publicado: (2018)

FADD the bad in head and neck cancer
por: Dent, Paul
Publicado: (2013)

Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7
por: Kalinowski, Felicity C., et al.
Publicado: (2012)

Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells
por: Tien, Yun, et al.
Publicado: (2020)

Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)

Could NSP5a3a be a target for head and neck cancer?
por: White, Martyn K., et al.
Publicado: (2010)

Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells
por: Macha, Muzafar A, et al.
Publicado: (2017)

Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
por: Stanton, P., et al.
Publicado: (1994)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck
por: Iberri, David J., et al.
Publicado: (2016)

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation
por: Suzuki, Shinsuke, et al.
Publicado: (2010)

Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
por: Pogorzelski, M, et al.
Publicado: (2014)

Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition?
por: De Ruyck, K, et al.
Publicado: (2008)

Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer
por: Drobin, Kimi, et al.
Publicado: (2020)

Commentary: Guideline for Performing Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Quantitative Image Analysis well
por: Beckwith, Bruce
Publicado: (2019)

Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells
por: van Rossum, Agnes GSH, et al.
Publicado: (2005)

The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
por: Avila, Jorge, et al.
Publicado: (2023)

Prospects for the future of epidermal growth factor receptor-tyrosine kinase inhibitors in combination with bevacizumab
por: Chikaishi, Yasuhiro, et al.
Publicado: (2020)

Rad51 in regulating the radiosensitivity of non‐small cell lung cancer with different epidermal growth factor receptor mutation status
por: Zhong, Xing, et al.
Publicado: (2015)

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro
por: Xie, Bo, et al.
Publicado: (2018)

Getting the basics right-staging in head and neck cancer
por: Patel, Nimesh Narendra, et al.
Publicado: (2009)

Psychosocial Implications of COVID-19 on Head and Neck Cancer
por: Dermody, Sarah M., et al.
Publicado: (2022)

Telomere length regulation through epidermal growth factor receptor signaling in cancer
por: Augustine, Titto, et al.
Publicado: (2017)

Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells
por: Chen, Oleg, et al.
Publicado: (2020)

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status
por: Hofman, P, et al.
Publicado: (2008)

Meta-analysis of the effects of anti-epidermal growth factor receptor on recurrent/metastatic head and neck squamous cell carcinoma
por: Xin, Yong, et al.
Publicado: (2018)

Epidermal growth factor receptor (EGFR) biology and Wnt developmental signaling highlight research endeavors of SCBA award winners
por: Jeang, Kuan-Teh
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ra7q5uptf7566gpo0omkqa4l07